XORTX Therapeutics Inc
NASDAQ:XRTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
XORTX Therapeutics Inc
NASDAQ:XRTX
|
CA |
|
Holcim AG
SIX:HOLN
|
CH |
|
F
|
Federal National Mortgage Association
XMUN:FNM
|
US |
|
I
|
Innocan Pharma Corp
XBER:IP4
|
IL |
|
T
|
Taiwan Semiconductor Manufacturing Co Ltd
F:TSFA
|
TW |
Shareholder Yield
Current shareholder yield for 
XRTX is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
XRTX Price
XORTX Therapeutics Inc
| Average Annual Return | -32.13% |
| Standard Deviation of Annual Returns | 55.84% |
| Max Drawdown | -99% |
| Market Capitalization | 5.2m USD |
| Shares Outstanding | 2 903 560 |
| Percentage of Shares Shorted | 1.31% |
XRTX Return Decomposition
Main factors of price return
Stock Splits
XRTX's latest stock split occurred on Apr 6, 2026
The company executed a 1-for-5 stock split, meaning that for every 5 shares held, investors received 1 new share.
Before the split, XRTX traded at 0.4295 per share. Afterward, the share price was about 2.32.
The adjusted shares began trading on Apr 6, 2026. This was stock split number 3 in XRTX's history, following the previous one in Nov 14, 2023.
